https://www.selleckchem.com/products/c188-9.html
Elevated troponin and brain natriuretic peptide did not differentiate subjects with severe CAD from nonsevere CAD, nor distinguish HFrEF from normal ejection fraction. Undertreatment was common. Of those with severe CAD, only 39% were prescribed an antiplatelet agent, and 53% received a statin. Of individuals with HFrEF, 50% or less received angiotensin blockers, beta blockers or antimineralocorticoids. Dynamic CT detects clinically covert CAD and HFrEF during AECOPD, identifying opportunities to improve outcomes well-established cardiac
Like
Comment
Share
